CZJ%NIHCU.BITNET@CUNYVM.CUNY.EDU (09/13/88)
Attached are the Table of Contents and articles of interest from the
NIH Guide to Grants and Contracts 8/5/88.
Jim Cassatt
--------------------------------------------------------------------
Vol. 17, No. 25, August 5, 1988
DATED ANNOUNCEMENTS (RFPs AND RFAs)
DEVELOPMENT AND MAINTENANCE OF A REPOSITORY AND DISTRIBUTION
CENTER FOR CRYOPRESERVED MOUSE EMBRYOS (RFP) .............(84/123).......... 1
National Institute of Allergy and Infectious Diseases
Index: ALLERGY AND INFECTIOUS DISEASES
CELLULAR AND MOLECULAR INTERACTIONS OF LIPOPROTEINS AND THE
HEMOSTATIC SYSTEM IN ATHEROSCLEROSIS AND THROMBOSIS (RFA) ..(126/180)....... 1
National Heart, Lung, and Blood Institute (991/1377)
Index: HEART, LUNG AND BLOOD
ONGOING PROGRAM ANNOUNCEMENTS
SMALL GRANTS PROGRAM FOR EPIDEMIOLOGY (PA) .........(186/357, 884/988)...... 2
National Cancer Institute
Index: CANCER
STUDIES ON NOSOLOGY OF ALCOHOL USE DISORDERS AND ASSOCIATED
DISABILITIES (PA) ...................................(360/613).............. 4
National Institute on Alcohol Abuse and Alcoholism
Index: ALCOHOL ABUSE AND ALCOHOLISM
CROSS-NATIONAL INVESTIGATIONS OF THE EPIDEMIOLOGY OF ALZHEIMER'S
DISEASE AND OTHER DEMENTIAS OF LATER LIFE (PA) ......(616/809).............. 7
National Institute on Aging
Index: AGING
DATED ANNOUNCEMENTS (RFPs AND RFAs)
DEVELOPMENT AND MAINTENANCE OF A REPOSITORY AND DISTRIBUTION
CENTER FOR CRYOPRESERVED MOUSE EMBRYOS
RFP AVAILABLE: NIH-NIAID-IAIDP-89-4
P.T. 34; K.W. 0780000, 0780005, 0755050
National Institute of Allergy and Infectious Diseases
The Genetics and Transplantation Biology Branch, Immunology, Allergy and
Immunologic Diseases Program of the National Institute of Allergy and
Infectious Diseases is soliciting proposals for the development and
maintenance of a repository and distribution center for cryopreserved mouse
embryos.
The offeror must have a high level of expertise in sophisticated
cryopreservation techniques, including maintenance of an inbred animal
facility, superovulation, collection of embryos, embryo freezing, and embryo
transfer.
RFP-NIH-NIAID-IAIDP-89-4 will be available on or about August 8, 1988.
Proposals will be due approximately 45 days after the RFP is released.
One cost-reimbursement type contract may be awarded as a result of this
solicitation. It is expected that the contract will have a three-year period
of performance. Any responsible offeror may submit a proposal which shall be
considered by the Government.
To receive a copy of this RFP, please supply this office with two
self-addressed mailing labels. All inquiries must be in writing and addressed
to the office below:
Ms. Joyce U. Sagami
National Institute of Allergy and Infectious Diseases
National Institutes of Health
5333 Westbard Avenue
Westwood Building, Room 707
Bethesda, Maryland 20892
This advertisement does not commit the Government to award a contract.
CELLULAR AND MOLECULAR INTERACTIONS OF LIPOPROTEINS AND THE HEMOSTATIC
SYSTEM IN ATHEROSCLEROSIS AND THROMBOSIS
RFA AVAILABLE: NIH-88-HL-21 H
P.T. 34; K.W. 0715040, 1002004, 1002008, 0785035
National Heart, Lung, and Blood Institute
Application Receipt Date: December 1, 1988
The Divisions of Heart and Vascular Diseases and of Blood Diseases and
Resources, National Heart, Lung, and Blood Institute (NHLBI) invite grant
applications to be considered in a single competition for support of
fundamental studies of atherogenesis and thrombosis. The emphasis of this
program is on elucidating the interactions of plasma lipoproteins, the
vascular endothelium and the hemostatic system. Copies of the RFA are
currently available from staff of NHLBI.
The program will support basic and clinical research addressing the molecular
interactions of plasma lipoproteins, the vascular endothelium and the
hemostatic system, and the underlying regulatory mechanisms that impact on
atherogenesis and thrombosis. It is expected that the re-search projects will
encompass a broad range of approaches and will require expertise from a
variety of disciplines including molecular and cellular biology, biochemistry,
hematology, metabolism and physiology. It is required that collaborative
research efforts between the two fields of atherosclerosis and thrombosis be
demonstrated.
Although approximately $2.2 million for this program is included in the
financial plans for fiscal year 1989, award of grants pursuant to this RFA is
contingent upon receipt of funds for this purpose. It is anticipated that up
to ten grants will be awarded under this program. The specific amount to be
Vol. 17, No. 25, August 5, 1988 - Page 1
funded, however, will depend on the merit and scope of the applications
received and the availability of funds.
Requests for copies of the RFA should be addressed to:
Momtaz Wassef, Ph.D.
Division of Heart and Vascular Diseases
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, Maryland 20892
Telephone: (301) 496-1978
OR
Carol Letendre, Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, Maryland 20892
Telephone: (301) 496-8966